Current therapeutic strategies for P23H RHO-Linked RP

10Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The first autosomal dominant mutation identified to cause retinitis pigmentosa in the North American population was the substitution of proline to histidine at position 23 of the rhodopsin gene (P23H RHO). Many biochemical studies have demonstrated that P23H mutation induces rhodopsin (RHO) misfolding leading to endoplasmic reticulum stress. Herein, we review current thinking of this topic.

Cite

CITATION STYLE

APA

Nguyen, A. T. H., Campbell, M., Kiang, A. S., Humphries, M. M., & Humphries, P. (2014). Current therapeutic strategies for P23H RHO-Linked RP. Advances in Experimental Medicine and Biology, 801, 471–476. https://doi.org/10.1007/978-1-4614-3209-8_60

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free